Brief: Dermapharm Confirms Guidance
March 28 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* DERMAPHARM HOLDING SE - BOARD OF MANAGEMENT CONFIRMS
GUIDANCE
PUBLISHED ON 14 MARCH 2024
Source text for Eikon: ID:nEQ7tWbZla
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit